Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
Combined Antibody Therapeutics
MeSH Descriptor Data 2024
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Combined Antibody Therapeutics
Tree Number(s)
D12.776.124.486.485.114.224.342
D12.776.124.790.651.114.224.306
D12.776.377.715.548.114.224.463
D26.310.358
Unique ID
D000094523
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000094523
Scope Note
Combinations of monoclonal antibodies used therapeutically to modulate the
IMMUNE SYSTEM
.
Entry Term(s)
Antibody Cocktail
Previous Indexing
Antibodies, Monoclonal (1987-2022)
See Also
Immunotherapy
Public MeSH Note
2023
History Note
2023
Date Established
2023/01/01
Date of Entry
2022/07/13
Revision Date
2022/07/13
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
analysis (AN)
biosynthesis (BI)
blood (BL)
cerebrospinal fluid (CF)
chemistry (CH)
classification (CL)
drug effects (DE)
economics (EC)
genetics (GE)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
physiology (PH)
poisoning (PO)
radiation effects (RE)
therapeutic use (TU)
toxicity (TO)
ultrastructure (UL)
urine (UR)
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Immunoproteins [D12.776.124.486]
Immunoglobulins [D12.776.124.486.485]
Antibodies [D12.776.124.486.485.114]
Antibodies, Monoclonal [D12.776.124.486.485.114.224]
Antibodies, Monoclonal, Humanized [D12.776.124.486.485.114.224.060]
Antibodies, Monoclonal, Murine-Derived [D12.776.124.486.485.114.224.075]
Combined Antibody Therapeutics [D12.776.124.486.485.114.224.342]
Infliximab [D12.776.124.486.485.114.224.608]
Single-Chain Antibodies [D12.776.124.486.485.114.224.785]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Serum Globulins [D12.776.124.790]
Immunoglobulins [D12.776.124.790.651]
Antibodies [D12.776.124.790.651.114]
Antibodies, Monoclonal [D12.776.124.790.651.114.224]
Antibodies, Monoclonal, Humanized [D12.776.124.790.651.114.224.060]
Antibodies, Monoclonal, Murine-Derived [D12.776.124.790.651.114.224.075]
Combined Antibody Therapeutics [D12.776.124.790.651.114.224.306]
Infliximab [D12.776.124.790.651.114.224.537]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Globulins [D12.776.377]
Serum Globulins [D12.776.377.715]
Immunoglobulins [D12.776.377.715.548]
Antibodies [D12.776.377.715.548.114]
Antibodies, Monoclonal [D12.776.377.715.548.114.224]
Antibodies, Monoclonal, Humanized [D12.776.377.715.548.114.224.200]
Antibodies, Monoclonal, Murine-Derived [D12.776.377.715.548.114.224.284]
Combined Antibody Therapeutics [D12.776.377.715.548.114.224.463]
Infliximab [D12.776.377.715.548.114.224.642]
Pharmaceutical Preparations [D26]
Drug Combinations [D26.310]
Adapalene, Benzoyl Peroxide Drug Combination [D26.310.032]
Aminophylline [D26.310.048]
Amlodipine Besylate, Olmesartan Medoxomil Drug Combination [D26.310.063]
Amlodipine, Valsartan Drug Combination [D26.310.094]
Amoxicillin-Potassium Clavulanate Combination [D26.310.102]
Artemether, Lumefantrine Drug Combination [D26.310.110]
Aspirin, Dipyridamole Drug Combination [D26.310.125]
Biphasic Insulins [D26.310.249]
Brimonidine Tartrate, Timolol Maleate Drug Combination [D26.310.312]
Albuterol, Ipratropium Drug Combination [D26.310.344]
Budesonide, Formoterol Fumarate Drug Combination [D26.310.348]
Buprenorphine, Naloxone Drug Combination [D26.310.352]
Cilastatin, Imipenem Drug Combination [D26.310.356]
Combined Antibody Therapeutics [D26.310.358]
Contraceptives, Oral, Combined [D26.310.360]
Dimenhydrinate [D26.310.368]
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D26.310.375]
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D26.310.391]
Emtricitabine, Rilpivirine, Tenofovir Drug Combination [D26.310.407]
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D26.310.423]
Ezetimibe, Simvastatin Drug Combination [D26.310.431]
Fluticasone-Salmeterol Drug Combination [D26.310.438]
Lidocaine, Prilocaine Drug Combination [D26.310.454]
Mometasone Furoate, Formoterol Fumarate Drug Combination [D26.310.469]
Multi-Ingredient Cold, Flu, and Allergy Medications [D26.310.500]
Piperacillin, Tazobactam Drug Combination [D26.310.625]
Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination [D26.310.750]
Tobramycin, Dexamethasone Drug Combination [D26.310.813]
Trimethoprim, Sulfamethoxazole Drug Combination [D26.310.875]
Expand All
Collapse All
Combined Antibody Therapeutics
Preferred
Concept UI
M000756050
Scope Note
Combinations of monoclonal antibodies used therapeutically to modulate the
IMMUNE SYSTEM
.
Terms
Combined Antibody Therapeutics
Preferred Term
Term UI
T001119510
Date
03/31/2022
LexicalTag
NON
ThesaurusID
NLM (2023)
Antibody Cocktail
Term UI
T001119511
Date
03/31/2022
LexicalTag
NON
ThesaurusID
NLM (2023)
page delivered in 0.138s